Acceptability and Tolerance Study of a New Oral Nutritional Supplement (ONS)

Study Overview
=================
Brief Summary
-----------------
Tolerance and Acceptability of new oral nutritional supplement - AYMES PARIS

Detailed Description
-----------------
To evaluate tolerance and acceptability of AYMES PARIS in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference,convenience etc. To obtain data to support an ACBS submissions for AYMES PARIS (to allow for prescription in the community at NHS expense).

Official Title
-----------------
Tolerance and Acceptability of AYMES PARIS

Conditions
-----------------
Malnutrition

Intervention / Treatment
-----------------
* Dietary Supplement: AYMES PARIS


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients (≥18 years) who are able to communicate their views regarding acceptability. Patients established on an oral nutritional supplement, being prescribed 1-2 ONS providing approximately 300kcal/day Patients expected to require oral nutritional supplementation for at least 2 further weeks. Informed consent obtained. Exclusion Criteria: Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study Patients requiring a milk-free diet Patients with medical or dietary contraindication to any feed ingredients (see appendix 2 of protocol for full list) Patients with significant renal or hepatic impairment Patients with swallowing impairment requiring thickened fluids Patients with inflammatory bowel disease or previous bowel resection.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Experimental<br>Patients established on an oral nutritional supplement, being prescribed 1-2 oral nutritional supplement (ONS) providing at least 300 kcal/day will be changed onto an equivalent prescription of AYMES PARIS for a period of 9 days. | Dietary Supplement: AYMES PARIS<br>* AYMES PARIS is a powdered, high energy, oral nutritional supplement to be mixed with milk as a drink. It provides 320 kcal and 12.2 g protein per 139 ml serving. It is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| GI side effects when using AYMES PARIS | Recording of absence/presence of any nausea, vomiting, abdominal pain, bloating / flatulence, when using AYMES PARIS as assessed by presence / absence of side effect compared to baseline period | 9 DAYS | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change to bodyweight of subjects when using AYMES PARIS | Recording of bodyweight (in kg) at start of study, start of intervention and end of intervention for comparison to investigate any trend in weight change during the intervention period compared to baseline | 9 DAYS | 
| Compliance with prescription of AYMES PARIS | Recording of amount of AYMES PARIS consumed by subjects compared to amount prescribed. Good compliance = >80% of prescribed being consumed. Same data collected for baseline product and compared with that of AYMES PARIS | 9 DAYS | 
| Bowel habits of subjects when using AYMES PARIS - frequency | Recording of bowel habits whilst subjects consuming AYMES PARIS, as assessed by frequency of bowel movements (number of stools per day) and compared to same data recorded during baseline period | 9 days | 
| Bowel habits of subjects when using AYMES PARIS - stool consistency | Recording of bowel habits whilst subjects consuming AYMES PARIS, as assessed by consistency of stools (assessed by Bristol Stool Chart) and compared to same data recorded during baseline period | 9 days |